INMB vs. AIRO
INMB (INmune Bio, Inc.) and AIRO (AIRO Group Holdings, Inc) are both stocks. INMB operates in Biotechnology (Healthcare), while AIRO operates in Aerospace & Defense (Industrials). Over the past year, INMB returned -77.59% vs -72.38% for AIRO. At a 0.28 correlation, their price movements are largely independent.
Performance
INMB vs. AIRO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, INMB achieves a -8.33% return, which is significantly higher than AIRO's -9.17% return.
INMB
- 1D
- -1.38%
- 1M
- -1.38%
- YTD
- -8.33%
- 6M
- -23.94%
- 1Y
- -77.59%
- 3Y*
- -46.06%
- 5Y*
- -40.35%
- 10Y*
- —
AIRO
- 1D
- -3.38%
- 1M
- 13.26%
- YTD
- -9.17%
- 6M
- -19.24%
- 1Y
- -72.38%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
INMB vs. AIRO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | |
|---|---|---|
INMB INmune Bio, Inc. | -8.33% | -80.30% |
AIRO AIRO Group Holdings, Inc | -9.17% | -36.59% |
Correlation
The correlation between INMB and AIRO is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.28 |
Correlation (All Time) Calculated using the full available price history since Jun 13, 2025 | 0.28 |
Fundamentals
INMB:
$38.02M
AIRO:
$175.93M
INMB:
-$1.61
AIRO:
$0.38
INMB:
1.94
AIRO:
0.24
INMB:
$0.00
AIRO:
$90.91M
INMB:
-$108.00K
AIRO:
$54.42M
INMB:
-$26.72M
AIRO:
-$28.77M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
INMB vs. AIRO — Risk / Return Rank
INMB
AIRO
INMB vs. AIRO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for INmune Bio, Inc. (INMB) and AIRO Group Holdings, Inc (AIRO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| INMB | AIRO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.02 | ||
| Sortino ratioReturn per unit of downside risk | +0.27 | ||
| Omega ratioGain probability vs. loss probability | 0.84 | 0.85 | 0.00 |
| Calmar ratioReturn relative to maximum drawdown | -0.92 | -0.91 | -0.01 |
| Martin ratioReturn relative to average drawdown | -1.02 | -1.28 | +0.26 |
Loading charts...
Drawdowns
INMB vs. AIRO - Drawdown Comparison
The maximum INMB drawdown since its inception was -95.98%, which is greater than AIRO's maximum drawdown of -81.13%. Use the drawdown chart below to compare losses from any high point for INMB and AIRO.
Loading charts...
Drawdown Indicators
| INMB | AIRO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.98% | -81.13% | -14.85% |
Max Drawdown (1Y)Largest decline over 1 year | -84.80% | -79.69% | -5.11% |
Max Drawdown (3Y)Largest decline over 3 years | -92.01% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -95.98% | — | — |
Current DrawdownCurrent decline from peak | -94.87% | -76.03% | -18.84% |
Average DrawdownAverage peak-to-trough decline | -60.75% | -54.83% | -5.92% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 75.79% | 56.40% | +19.39% |
Volatility
INMB vs. AIRO - Volatility Comparison
The current volatility for INmune Bio, Inc. (INMB) is 17.60%, while AIRO Group Holdings, Inc (AIRO) has a volatility of 30.17%. This indicates that INMB experiences smaller price fluctuations and is considered to be less risky than AIRO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| INMB | AIRO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 17.60% | 30.17% | -12.57% |
Volatility (6M)Calculated over the trailing 6-month period | 51.12% | 62.81% | -11.69% |
Volatility (1Y)Calculated over the trailing 1-year period | 99.62% | 93.28% | +6.34% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 85.62% | 130.60% | -44.98% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 92.70% | 130.60% | -37.90% |
Dividends
INMB vs. AIRO - Dividend Comparison
Neither INMB nor AIRO has paid dividends to shareholders.
Financials
INMB vs. AIRO - Financials Comparison
This section allows you to compare key financial metrics between INmune Bio, Inc. and AIRO Group Holdings, Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
INMB and AIRO have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AIRO has higher volatility (30.17%) compared to INMB (17.60%). In terms of maximum drawdown, INMB dropped -95.98% vs AIRO's -81.13%.
INMB currently has the higher Sharpe Ratio (-0.78 vs -0.80), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for INMB and AIRO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer